Ubisoft Shares Slide After Company Warns of Continued Fiscal Losses SpaceX Scrubs Starship Test Flight Eyes Friday Retry Amid IPO Preparations Hindalco Investors Eye MediumTerm Gains Amid Q4 Profit Halve but Valuation Concerns Linger Bond Bull Market Shows Signs of Pause but Remains Resilient Expert Suggests Applied Materials Receives Positive LongTerm Outlook from Argus Research Indian Stocks in Focus as Gift Nifty Hints at Positive Open Meesho Max Financial Services GIPCL Eyed Core Laboratories Q1 2026 Earnings EPS Falls 45 Short of Estimates Stock Declines DUK Q1 2026 Earnings Utility Giant Beats Estimates as Regulatory Gains Offset Cost Pressures PRTA Q1 2026 Earnings EPS Surges 27169 Above Estimates Despite No Revenue Stock Edges Lower Value Line Inc Q1 2026 Earnings EPS of 069 Surprises Despite Revenue Silence PM Q1 2026 Earnings Earnings Beat Expectations Amid Solid Pricing Power NAT Q4 2025 Earnings Significant EPS Miss Sends Stock Lower Soren Acquisition Corp SORN Holds Steady at 992 as Support and Resistance Define Trading Range Mondelez MDLZ Edges Lower as Consumer Staples Sector Faces Headwinds Rekor Systems REKR Slides 3 as Stock Tests Key Support at 070 Amid Low Volume Martin Midstream Partners MMLP Holds Steady Near Support Level with Minimal Change LivaNova LIVN Retreats 183 as Stock Faces Resistance Near 78 Zone Michael Price Advocates Contrarian Investing to Navigate Market Volatility Subramanian Swamy Seeks Ban on Cement Imports from Pakistan Citing National Security Risks Dulux Parent AkzoNobel Stock Surges 21 on Takeover Bid European Markets Rise Amid Iran Tensions Gold Prices Face Potential Headwinds from Peace Talks and Rate Hike Concerns Indian States Face Prolonged Fiscal Squeeze as Welfare Costs Outpace Revenue Growth Morgan Stanley Rupee Opens Weaker by 7 Paise at 9575 Against US Dollar Tracking Global Headwinds ValueQuests Sameer Shah Advocates Private Equity Approach to Public Markets for LongTerm Alpha IN8bio Inc INAB Q1 2026 Earnings EPS Surprise of 63 Highlights Cost Discipline in PreRevenue Biotech SRX Health Solutions SRXH Holds Near Support After Modest Uptick